0001209191-18-042183.txt : 20180710
0001209191-18-042183.hdr.sgml : 20180710
20180710171810
ACCESSION NUMBER: 0001209191-18-042183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180706
FILED AS OF DATE: 20180710
DATE AS OF CHANGE: 20180710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCOURT Thomas A
CENTRAL INDEX KEY: 0001478448
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 18947583
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS INC
STREET 2: 320 BENT STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-06
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001478448
MCCOURT Thomas A
C/O IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Commercial Officer
Class B Common Stock
2018-07-06
4
M
0
30000
5.48
A
30000
D
Class B Common Stock
2018-07-06
4
S
0
30000
20.00
D
0
D
Class A Common Stock
76150
D
Employee Stock Option(Right to Buy)
5.48
2018-07-06
4
M
0
30000
0.00
D
2019-09-07
Class B Common Stock
30000
130000
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
The reporting person acquired a total of 1,637 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 29, 2018.
The option vests in four equal installments based on the issuer's achievement of certain regulatory and commercial milestones. Upon achievement of regulatory or commercial milestones, the option vested as to 40,000 shares of Class B Common Stock on each of October 24, 2011, December 21, 2012 and January 4, 2017.
/s/ Conor Kilroy, Attorney-in-Fact
2018-07-10